A novel immunomodulator, FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 mice.
暂无分享,去创建一个
K. Watabe | A. Matsumoto | T. Kohno | H. Yoshikawa | T. Fujita | M. Hirose | K. Hirayama | T. Kohno | Takumi Tsuji | M. Hayashi | R. Iwatsuki
[1] K. Watabe,et al. A novel immunomodulator, FTY720, prevents spontaneous dermatitis in NC/Nga mice. , 2004, Biological & pharmaceutical bulletin.
[2] E. Mukai,et al. Clinical study of fk506 in patients with myasthenia gravis , 2003, Muscle & nerve.
[3] S. Mulgaonkar,et al. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study , 2003, Transplantation.
[4] K. Budde,et al. Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicine. , 2003, International journal of clinical pharmacology and therapeutics.
[5] M. Fukuzawa,et al. The Effect of a Novel Immunosuppressant, FTY720, in Mice Without Secondary Lymphoid Organs , 2003, Surgery Today.
[6] J. Nedelman,et al. Pharmacodynamics of Single Doses of the Novel Immunosuppressant FTY720 in Stable Renal Transplant Patients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] K. Budde,et al. FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients. , 2002, Transplantation Proceedings.
[8] Michael D. Davis,et al. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.
[9] K. Budde,et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. , 2002, Journal of the American Society of Nephrology : JASN.
[10] H. Rosen,et al. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.
[11] T. Hanano,et al. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. , 2000, Journal of medicinal chemistry.
[12] L. Feng,et al. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. , 2000, Trends in pharmacological sciences.
[13] K. Sugahara,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. , 1998, Journal of immunology.
[14] H. Kataoka,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. , 1998, Journal of immunology.
[15] P. Karachunski,et al. Nasal Administration of Synthetic Acetylcholine Receptor T Epitopes Affects the Immune Response to the Acetylcholine Receptor and Prevents Experimental Myasthenia Gravis a , 1998, Annals of the New York Academy of Sciences.
[16] P. Karachunski,et al. Immunization of bm12 Mice with High Doses of Acetylcholine Receptor Overcomes Their Resistance to Experimental Autoimmune Myasthenia Gravis a , 1998, Annals of the New York Academy of Sciences.
[17] T. Fujita,et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720 , 1995 .
[18] T. Okumoto,et al. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. , 1994, The Journal of antibiotics.
[19] E. Ishikawa,et al. A more sensitive enzyme immunoassay of anti-insulin IgG in guinea pig serum with less non-specific binding of normal guinea pig IgG. , 1985, Journal of Biochemistry (Tokyo).
[20] P. Berman,et al. Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis , 1980, The Journal of experimental medicine.
[21] P. Berman,et al. Experimental myasthenia gravis. A murine system , 1980, The Journal of experimental medicine.
[22] S. Froehner,et al. Comparison of the subunits of Torpedo californica acetylcholine receptor by peptide mapping. , 1979, Biochemistry.
[23] R. Almon,et al. Acetylcholine receptor antibodies in myasthenia gravis. , 1975, The New England journal of medicine.
[24] K. Watabe,et al. Antibodies to food antigens in Japanese patients with type 1 diabetes mellitus. , 2002, Diabetes research and clinical practice.